MAY 19·Business InsiderMed
EQS-News: Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® ( ustekinumab-aauz )
EQS-News: Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for ...
StockHealthcare · Medical Care Facilities
$FSNUF
Fresenius SE & Co. KGaA
Price · $FSNUFvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $FSNUF in the last 7 days.
Insider · 30dFeed →
No SEC Form 4 filings for $FSNUF in the last 30 days.
Top stories · $FSNUFMore →
MAY 9·Zacks Commentary
Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates
PCRX reports mixed first-quarter results, wherein earnings beat estimates but revenues miss the same. Exparel sales witness weak year-over-year growth.
MAY 7·Zacks Commentary
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y
Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.